Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12762697rdf:typepubmed:Citationlld:pubmed
pubmed-article:12762697lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:12762697lifeskim:mentionsumls-concept:C0699900lld:lifeskim
pubmed-article:12762697lifeskim:mentionsumls-concept:C0243125lld:lifeskim
pubmed-article:12762697lifeskim:mentionsumls-concept:C0486805lld:lifeskim
pubmed-article:12762697lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:12762697lifeskim:mentionsumls-concept:C1311317lld:lifeskim
pubmed-article:12762697pubmed:issue11lld:pubmed
pubmed-article:12762697pubmed:dateCreated2003-5-23lld:pubmed
pubmed-article:12762697pubmed:abstractText[structure: see text] By relying on the asymmetric aldol reactions of chiral ketones, a highly stereocontrolled synthesis of each of the C(17)-C(22) and C(23)-C(35) degradation fragments of reidispongiolide A has been achieved. This permits a configurational assignment of the complete C(17)-C(36) region of this antimitotic macrolide, along with providing advanced intermediates for a projected total synthesis.lld:pubmed
pubmed-article:12762697pubmed:languageenglld:pubmed
pubmed-article:12762697pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12762697pubmed:citationSubsetIMlld:pubmed
pubmed-article:12762697pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12762697pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12762697pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12762697pubmed:statusMEDLINElld:pubmed
pubmed-article:12762697pubmed:monthMaylld:pubmed
pubmed-article:12762697pubmed:issn1523-7060lld:pubmed
pubmed-article:12762697pubmed:authorpubmed-author:PatersonIanIlld:pubmed
pubmed-article:12762697pubmed:authorpubmed-author:KnustHennerHlld:pubmed
pubmed-article:12762697pubmed:authorpubmed-author:AshtonKateKlld:pubmed
pubmed-article:12762697pubmed:authorpubmed-author:BrittonRobert...lld:pubmed
pubmed-article:12762697pubmed:issnTypePrintlld:pubmed
pubmed-article:12762697pubmed:day29lld:pubmed
pubmed-article:12762697pubmed:volume5lld:pubmed
pubmed-article:12762697pubmed:ownerNLMlld:pubmed
pubmed-article:12762697pubmed:authorsCompleteYlld:pubmed
pubmed-article:12762697pubmed:pagination1963-6lld:pubmed
pubmed-article:12762697pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:12762697pubmed:meshHeadingpubmed-meshheading:12762697...lld:pubmed
pubmed-article:12762697pubmed:meshHeadingpubmed-meshheading:12762697...lld:pubmed
pubmed-article:12762697pubmed:meshHeadingpubmed-meshheading:12762697...lld:pubmed
pubmed-article:12762697pubmed:meshHeadingpubmed-meshheading:12762697...lld:pubmed
pubmed-article:12762697pubmed:meshHeadingpubmed-meshheading:12762697...lld:pubmed
pubmed-article:12762697pubmed:meshHeadingpubmed-meshheading:12762697...lld:pubmed
pubmed-article:12762697pubmed:meshHeadingpubmed-meshheading:12762697...lld:pubmed
pubmed-article:12762697pubmed:meshHeadingpubmed-meshheading:12762697...lld:pubmed
pubmed-article:12762697pubmed:meshHeadingpubmed-meshheading:12762697...lld:pubmed
pubmed-article:12762697pubmed:year2003lld:pubmed
pubmed-article:12762697pubmed:articleTitleToward the synthesis of reidispongiolide a: stereocontrolled synthesis of the C17-C22 and C23-C35 degradation fragments.lld:pubmed
pubmed-article:12762697pubmed:affiliationDepartment of Chemistry, University Chemical Laboratory, Lensfield Road, Cambridge CB2 1EW, United Kingdom. ip100@cam.ac.uklld:pubmed
pubmed-article:12762697pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12762697lld:pubmed